Results 251 to 260 of about 1,373,329 (318)

Gut microbiome in advanced non-small cell lung cancer: effect of chemotherapy and impact on efficacy. [PDF]

Transl Lung Cancer Res
Trachu N, Sensorn I, Khiewngam K, Monnamo N, Chantratita W, Sirachainan E, Reungwetwattana T, Oranratnachai S.   +7 more
europepmc   +1 more source

Nanoplatforms for Sentinel and Tumor‐Draining Lymph Node Mapping: From Visualization to Pathway‐Informed Staging

Advanced Healthcare Materials, EarlyView.
Lymphotropic nanoplatforms integrate multimodal imaging with therapeutic guidance to map sentinel and tumor‐draining lymph nodes, revealing functional drainage, metastatic involvement, and nodal accessibility, while providing mechanistic insight to support precision surgical and therapeutic interventions.
Xu Chen, Nina Li, Meiyan Zou, Zihao Zhou, Rongwei Xu, Weiyao Feng, Xinyuan Zhao, Li Cui   +7 more
wiley   +1 more source

Temporal Immune and Metabolic Shifts Drive the Anti‐Tumor Efficacy of Resiquimod‐Loaded Nanoparticles in Peritoneal Carcinomatosis

Advanced Healthcare Materials, EarlyView.
Peritoneal carcinomatosis is a hard‐to‐treat spread of abdominal cancers that often returns after therapy. Nanoparticles were developed to retain an immune‐boosting drug in the abdomen. When combined with chemotherapy in mice, this approach eliminated tumors in many cases and prevented recurrence, helping the immune system mount a stronger, longer ...
Vanessa Chan, Po‐Han Chao, XuXin Sun, Jun Han, Sarah MacPherson, Lucas J. Andrew, Noah Y. Brittain, Tien Do, Marcel B. Bally, Julian J. Lum, Shyh‐Dar Li   +10 more
wiley   +1 more source

Fosnetupitant for long-delayed chemotherapy-induced nausea and vomiting in oxaliplatin-based regimens: a prospective observational study (LODEC-N). [PDF]

Cancer Chemother Pharmacol
Iimura Y, Iihara H, Aoyama T, Hayashi T, Ishibashi M, Sasuga C, Furukawa N, Anzai E, Ijichi Y, Kuroda S.   +9 more
europepmc   +1 more source

Refractory ultra-high-risk Choriocarcinoma achieving complete response to intensive multi-agent and intrathecal chemotherapy and anti-PD-L1 therapy. [PDF]

Gynecol Oncol Rep
Venegas L, Grant B, Veneziani AC, Lheureux S, Deljoomanesh S, Millar BA, Bouchard-Fortier G, Jivraj N, Bowering V, Pulman K, Oza AM.   +10 more
europepmc   +1 more source

Overcoming chemoresistance in esophageal cancer with synergistic strategies. [PDF]

Front Immunol
Gao C, Zhang T, Li G, Zhang W, Chen H, Li D, Xu J, Li M, Wang R, Xing Y, Zhan J, Ren Z, Xue X, Liang W, Sun X, Zhang X, Liang X, Zhan H, Zhang Z, Chu X.   +19 more
europepmc   +1 more source

Chemotherapy in Schwannomatosis: Justified Strategy or Deviation From Surgical Standard of Care? [PDF]

Clin Case Rep
Awan MA.
europepmc   +1 more source

Global research trends on intra-arterial chemotherapy for retinoblastoma: A bibliometric and visualized study. [PDF]

Medicine (Baltimore)
Visconti-Lopez FJ, Saal-Zapata G.
europepmc   +1 more source